the aid library

LIST OPTIONS

Filter

3722

Addressing gender inequalities in national action plans on antimicrobial resistance

World Health Organisation (WHO) (2024) C_WHO

National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Worldwide rates of diagnosis and effective treatment for cystic fibrosis

Guo, J.; Garratt, A.; Hill, A. Journal of Cystic Fibrosis (2022) CC

Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma... more

Download (802)

View PDF (1239)

Technical Notes on Drinking-Water, Sanitation and Hygiene In Emergencies

Karen Vilholth WHO, WEDC, and IWMI (2011)

Download (847)

View PDF (1587)

Clinical Management of Rape Survivors: Developing protocols for use with refugees and internally displaced persons (Arabic edition)

UNHCR; WHO; UNFPA (2004) C_WHO

Download (359)

View PDF (704)

Report on the 1st Symposium on Teenage Pregnancy in Uganda 2013

Ministry of Health Uganda; UNFPA; Marie Stopes Uganda, WHO (2013) C_WHO

THEME: TEENAGE PREGNANCY AN OBSTACLE TO MATERNAL HEALTH; LET US STOP IT NOW. 5th November 2013

Download (371)

View PDF (537)

Families with disabled children in different European countries

Paola Di Giulio, Dimiter Philipov, and Ina Jaschinski (2014) C2

Families and Societies Working Paper Series Changing families and sustainable societies: Policy contexts and diversity over the life course and across generations

Download (203)

View PDF (299)

Trauma and PTSD in the WHO World Mental Health Surveys

Kessler, R.C., Aguilar-Gaxiola, S., Alonso, J., et al. European of Psychotraumatology (2017) CC

Objective: To review research on associations of trauma type with PTSD in the WHO World Mental Health (WMH) surveys, a series of epidemiological surveys that obtained representative data on trauma-specific PTSD.

Download (205)

View PDF (214)

HIV/AIDS and orphan and vulnerable children (OVC) in Zimbabwe

H. Yeboah International Journal of Current Research; ResearchGate (2018) C2

International Journal of Current Research Vol. 10, Issue, 04, pp.68266-68270, April, 2018 ISSN: 0975-833X

Download (150)

View PDF (158)

Chăm sóc SỨC KHOẺ TÂM THẦN trước đại dịch Covid-19

See text (2020) C2

Mental health and psychosocial considerations during the COVID-19 outbreak

Download (224)

View PDF (237)

Global report on ageism

World Health Organization WHO (2021) C_WHO

Available in English, French and Spanish

External Link

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

GBD2019 Dementia Forecasting Coolaborators (2022) CC

Lancet Public health 2022 January 6, 2022 https://doi.org/10.1016/ S2468-2667(21)00249-8 Growth in the number of individuals living with dementia underscores the need for public health planning efforts and policy to address the needs of this group. Country-level estimates can be used to inform nati... more

Download (294)

View PDF (304)

Vector control and the elimination of gambiense human African trypanosomiasis

World Health Organization WHO (2022) C_WHO

The main purpose of the meeting was to review tsetse control tools, activities and their contribution to the elimination of gHAT and the monitoring thereof. Seven endemic countries provided reports on recent and ongoing vector control interventions at the national level (Angola, Cameroon, Côte d’... more

Download (121)

View PDF (176)

Target product profile for a gambiense human African trypanosomiasis test to identify individuals to receive widened treatment

World Health Organization WHO (2022) C_WHO

The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form... more

Download (199)

View PDF (218)

Report of the fourth WHO stakeholders meeting on gambiense and rhodesiense human African trypanosomiasis elimination: virtual meeting, 1–3 June 2021

World Health Organization WHO (2021) C_WHO

Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan... more

External Link

Monitoring the elimination of human African trypanosomiasis at continental and country level: Update to 2018

Franco, JR.; Cecchi, G.; Priotto, G.; Paone, M.; Diarra, A. et al. (2020) CC

Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in... more

Epidemiology of human African trypanosomiasis

Franco J, Simarro P, Diarra A, Jannin J (2014) CC

The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci�... more

Download (349)

View PDF (571)

Working together to promote health. WHO Tanzania Annual Report 2017

World Health Organization WHO, Regional Office for Africa (2018) C_WHO

It provides insight into WHO’s work that aims to improve the health of the people of the United Republic of Tanzania in collaboration with key stakeholders.

Download (207)

View PDF (229)

Good Practice Manual On HIV and AIDS awareness raising and impact

Restless Development; Irish Aid (2011) C1

Download (105)

View PDF (142)

90-90-90 On the right track towards the global target

J. Amon; V. Andreeva; S. Basu; et al. UNAIDS (2016) C2

UNAIDS Joint United Nations Programme on HIV/AIDS